Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Even though annotations already mark the tool read-only, open-world, and idempotent, the description adds rich behavioral detail: graceful degradation of LEI/FIGI enrichment, explicit reporting of unresolved identifiers, returning figi_candidates instead of asserting a match, source-labelled identifiers, and ISIN-to-LEI mapping. These details materially change how an agent should interpret results and are not present in annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense and long, but almost every clause earns its place given the tool's dual entity types and multiple identifier systems. It front-loads the core purpose and usage instruction before diving into supported types. It loses a point for some overpacked parentheticals that reduce scannability.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

There is no output schema, so the description must carry the burden of explaining return behavior — and it does: labelled identifiers, unresolved lists, figi_candidates, ownership data, degradation paths, and per-type return fields. The tool is complex, yet an agent gets enough operational guidance to know what to expect and how to handle ambiguous or failed resolutions.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is already 100%, but the description adds substantial meaning to the value parameter: accepted input forms (ticker, CIK, ISIN, name), the warning to pass only the entity name, the bond-issuer formatting guidance, and the note that trailing security-class words match nothing. This is exactly the kind of pragmatic disambiguation the raw schema could not provide.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description names a specific verb and resource: resolve a user-spoken name into canonical/official identifiers required by other tools. It enumerates concrete entity types (company, drug) and the identifier systems involved, and the trigger phrases make it instantly recognizable. It is clearly distinguished from sibling tools like entity_profile by focusing on identifier resolution rather than profile enrichment.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly says "Use FIRST whenever you have a name but need an ID," which gives a clear positive trigger condition. It does not explicitly name alternatives or state when not to use it, so an agent has to infer the boundary against siblings like entity_profile or search_within. The supported-type detail partially compensates by scoping acceptable inputs.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Multiple tools have unclear boundaries: ask_pipeworx_beta currently behaves identically to ask_pipeworx, and the five Polymarket tools (arbitrage, edges, bet_research, fill_risk, edge_tracker) overlap heavily in the 'should I bet on X' use case. The detailed descriptions help, but an agent could easily misselect between these clusters.

Naming Consistency2/5

Naming is highly inconsistent: verb_noun (ask_pipeworx, compare_entities, resolve_entity), noun_noun (entity_profile, table_meta, polymarket_edges), single verbs (remember, forget, recall), and brand-prefixed compounds (pipeworx_trending, polymarket_kalshi_spread) are all mixed together. The server name 'Stat Gl' also doesn't align with the Pipeworx-heavy tool set.

Tool Count2/5

34 tools is well beyond the 25+ threshold that signals an oversized surface, and the set spans disparate domains: data querying, prediction markets, entity research, memory, subscriptions, and even niche utilities like generate_llms_txt and scan_dependency. While each tool has a described purpose, the count feels bloated for a coherent server.

Completeness4/5

Within its actual domains, coverage is strong: query, grounded verification, deep research, claim validation, entity profiles, comparisons, memory CRUD, and subscription lifecycle are all present, plus a complete Statistics Greenland browse/schema/query trio. Minor gaps exist (e.g., limited subscription event types, US-centric company profiles), but agents can typically find a working path without dead ends.